Agilent Technologies and Callida Genomics sign licensing agreement for DNA microarray patents
21-May-2002 -
PALO ALTO and SUNNYVALE, Calif., May 20, 2002
Agilent Technologies Inc. and Callida Genomics Inc., a majority-owned subsidiary of Hyseq Pharmaceuticals Inc., today announced a non-exclusive licensing agreement that grants Callida both up-front fees and potential running royalties, and gives ...
Agilent Technologies
genomics
Life Sciences
+1